ATARA BIOTHERAPEUTICS, INC. (ATRA) Operating cash flow 2016–2025
ATARA BIOTHERAPEUTICS, INC. (ATRA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$50.9MFY2025 · since FY2016: -$60.0M → -$50.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$50.9M | +25.9% |
| FY2024 | -$68.7M | +64.4% |
| FY2023 | -$193.0M | +28.6% |
| FY2022 | -$270.4M | -22.6% |
| FY2021 | -$220.5M | -22.0% |
| FY2020 | -$180.8M | +23.3% |
| FY2019 | -$235.6M | -31.1% |
| FY2018 | -$179.8M | -105.4% |
| FY2017 | -$87.5M | -45.8% |
| FY2016 | -$60.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice